A new study questions the use of stents in certain patients; the House is expected to pass CHIP funding, but how to pay for it continues to be debated; and nearly all older, poorer people will have access to cheaper ACA plans in 2018.
Stents may not provide as much benefit for heart patients as originally thought. According to The Wall Street Journal, researchers found stents didn’t provide patients with angina with a significant improvement in exercise time on a treadmill. These patients are only a small number of the total population of patients who currently receive stents, but the findings could have a big impact on the business of stent manufacturers. The study’s findings do not apply to patients having heart attacks; past studies have shown stents can save lives in these patients.
Although there is still debate on how to pay for funding for the Children’s Health Insurance Program (CHIP), the House is expected to pass legislation to refinance CHIP. The bill would ensure funding for the program, but it is expected to pass mostly along party lines, with a tougher road to pass in the Senate, according to The New York Times. Both parties have agreed to fund CHIP for 5 years and community health centers for 2 years, but are split on how to pay for the funding. Republicans want to use money in an Affordable Care Act (ACA) fund for public health efforts, which Democrats are strongly opposed to.
The Trump administration’s decision to end funding for cost-sharing reduction payments is having an unintended consequence: more people will have cheaper or free options in 2018. The Washington Post reported that the move has led to increased federal subsidies and that older people with low incomes will benefit the most. In 98% of counties, this population would be able to get a bronze plan with no premium. It is unclear yet if this new quirk to the ACA will offset expected enrollment losses.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More